In vivo tomographic imaging with fluorescence and MRI using tumor-targeted dual-labeled nanoparticles

International Journal of Nanomedicine

Volumn 9, Issue 1, 2013, Pages 33-41

  Zhang, Yue ^a   Zhang, Bin ^a   Liu, Fei ^a,b   Luo, Jianwen ^a,c   Bai, Jing ^a  

^a School of Medicine   (China)

^b Tsinghua University   (China)

^c TSINGHUA UNIVERSITY   (China)

Author keywords

Dual modality; Fuorescence molecular tomography (FMT); Magnetic resonance imaging (MRI); Nanoparticle

Indexed keywords

DYE; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; IRON OXIDE; MAGNETIC IRON OXIDE NANOPARTICLE; NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL LABELING; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FLOURESCENCE MOLECULAR TOMOGRAPHY; FLUORESCENCE; FLUORESCENCE IMAGING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEAR INFRARED IMAGING SYSTEM; NEOPLASM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; QUANTITATIVE ANALYSIS; TUMOR CELL; TUMOR DIAGNOSIS; TUMOR LOCALIZATION; TUMOR VOLUME;

DUAL-MODALITY; FLUORESCENCE MOLECULAR TOMOGRAPHY (FMT); MAGNETIC RESONANCE IMAGING (MRI); NANOPARTICLE;

BREAST NEOPLASMS; CARBOCYANINES; CELL LINE, TUMOR; CONTRAST MEDIA; FERRIC COMPOUNDS; FLUORESCENT DYES; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MICROSCOPY, FLUORESCENCE; MULTIMODAL IMAGING; NANOPARTICLES; PARTICLE SIZE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STAINING AND LABELING; TOMOGRAPHY;

EID: 84890457865     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S52492     Document Type: Article

References (33)

1. Zhang B, Liu S, Liu F, et al. Simultaneous fluorescence and positron emission tomography for in vivo imaging of small animals. J Biomed Opt. 2011;16(12):120511.
2. Lee DE, Koo H, Sun IC, Ryu JH, Kim K, Kwon IC. Multifunctional nanoparticles for multimodal imaging and theragnosis. Chem Soc Rev. 2012;41:2656-2672.
3. Chen X, Conti PS, Moats RA. In vivo near-infrared fuorescence imaging of integrin alphavbeta3 in brain tumor xenografts. Cancer Res. 2004;64:8009-8014.
4. Rudin M, Weissleder R. Molecular imaging in drug discovery and development. Nat Rev Drug Discov. 2003;2:123-131.
5. Liu F, Zhang Y, Liu S, et al. Monitoring of tumor response to Au nanorod-indocyanine green conjugates mediated therapy with fuorescence imaging and positron emission tomography. IEEE Trans Multimed. 2013;15(5):1025-1030.
6. Song X, Wang D, Chen N, Bai J, Wang H. Reconstruction for free-space fluorescence tomography using a novel hybrid adaptive finite element algorithm. Opt Express. 2007;15(26):18300-18317.
7. Stelter L, Pinkernelle JG, Michel R, et al. Modification of aminosi-lanized superparamagnetic nanoparticles: feasibility of multimodal detection using 3T MRI, small animal PET, and fluorescence imaging. Mol Imaging Biol. 2010;12(1):25-347.
8. Yang L, Peng XH, Wang YA, et al. Receptor-targeted nanoparticles for in vivo imaging of breast cancer. Clin Cancer Res. 2009;15(14): 4722-4732.
9. Niedre M, Ntziachristos V. Elucidating structure and function in vivo with hybrid fuorescence and magnetic resonance imaging. Proc IEEE Inst Electr Electron Eng. 2008;96(3):382-396.
10. Sosnovik DE, Nahrendorf M, Deliolanis N, et al. Fluorescence tomography and magnetic resonance imaging of myocardial macrophage infiltration in infracted myocardium in vivo. Circulation. 2007;115: 1384-1391.
11. Kelly KA, Allport JR, Tsourkas A, Shinde-Patil VR, Josephson L, Weissleder R. Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ Res. 2005;96:327-336.
12. Bardhan R, Chen W, Bartels M, et al. Tracking of multimodal therapeutic nanocomplexes targeting breast cancer in vivo. Nano Lett. 2010;10(12):4920-4928.
13. Smith L, Kuncic Z, Ostrikov K, Kumar S. Nanoparticles in cancer imaging and therapy. J Nanomat. 2012;2012:1-7.
14. Montet X, Montet-Abou K, Reynolds F, Weissleder R, Josephson L. Nanoparticle imaging of integrins on tumor cells. Neoplasia. 2006;8(3): 214-222.
15. Helman EE, Newman JR, Dean NR, Zhang W, Zinn KR, Rosenthal EL. Optical imaging predicts tumor response to anti-EGFR therapy. Cancer Biol Ther. 2010;10(2):166-171.
16. Liao C, Sun Q, Liang B, Shen J, Shuai X. Targeting EGFR-over-expressing tumor cells using Cetuximab-immunomicelles loaded with doxorubicin and superparamagnetic iron oxide. Eur J Radiol. 2011;80(3):699-705.
17. Tsutsui S, Ohno S, Murakami S, Hachitanda Y, Oda S. Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer. Breast Cancer Res Treat. 2002;71(1):67-75.
18. Ke S, Wen X, Gurfnkel M, et al. Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Res. 2003;63:7870-7875.
19. Mulder WJ, Castermans K, van Beijnum JR, et al. Molecular imaging of tumor angiogenesis using alphavbeta3-integrin targeted multimodal quantum dots. Angiogenesis. 2009;12:17-24.
20. Cai W, Chen K, Li ZB, Gambhir SS, Chen X. Dual-function probe for PET and near-infrared fuorescence imaging of tumor vasculature. J Nucl Med. 2007;48:1862-1870.
21. Davis SC, Samkoe KS, O'Hara JA, Gibbs-Strauss SL, Paulsen KD, Pogue B W. Comparing implementations of magnetic-resonance-guided fluorescence molecular tomography for diagnostic classification of brain tumors. J Biomed Opt. 2010;15(5):051602.
22. Jia Q, Zeng J, Qiao R, et al. Gelifcation: an effective measure for achieving differently sized biocompatible Fe3O4 nanocrystals through a single preparation recipe. J Am Chem Soc. 2011;133:19512-19523.
23. Qiao R, Jia Q, Hüwel S, et al. Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier. ACS Nano. 2012;6(4): 3304-3310.
24. Liu S, Jia B, Qiao R, et al. A novel type of dual-modality molecular probe for MR and nuclear imaging of tumor: preparation, characterization and in vivo application. Mol Pharm. 2009;6(4):1074-1082.
25. Liu X, Wang D, Bai J. Fluorescence molecular tomography with optimal radon transform based surface reconstruction. Conf Proc IEEE Eng Med Biol Soc. 2009;2009:1404-1407.
26. Deliolanis N, Lasser T, Hyde D, Soubret A, Ripoll J, Ntziachristos V. Free-space fuorescence molecular tomography utilizing 360 degrees geometry projections. Opt Lett. 2007;32(4):382-384.
27. Song X, Wang D, Bai J, Wang H. Reconstruction for free-space fuorescence tomography using a novel hybrid adaptive fnite element algorithm. Opt Express. 2007;15(26):18300-18317.
28. Paudyal P, Paudyal B, Iida Y, et al. Dual functional molecular imaging probe targeting CD20 with PET and optical imaging. Oncol Rep. 2009;22(1):115-119.
29. Wehrl H F, Judenhofer MS, Wiehr S, Pichler BJ. Pre-clinical PET/MR: technological advances and new perspectives in biomedical research. Eur J Nucl Med Mol Imaging. 2009;36 Suppl 1:S56-S68.
30. Stuker F, Baltes C, Dikaiou K, et al. Hybrid small animal imaging system combining magnetic resonance imaging with fuorescence tomography using single photon avalanche diode detectors. IEEE Trans Med Imaging. 2011;30(6):1265-1273.
31. Zhang G, Cao X, Zhang B, Liu F, Luo J, Bai J. MAP estimation with structural priors for fuorescence molecular tomography. Phys Med Biol. 2013;58(2):351-372.
32. Cai W, Shin DW, Chen K, et al. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett. 2006; 6(4):669-676.
33. Weissleder R, Stark DD, Engelstad BL, et al. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol. 1989; 152(1):167-173.